Summary: Twenty-five patients with different stages of liver cirrhosis were evaluated with regard to the degree of liver synthesis reduction, the extent of the decrease of blood coagulation factors and/or alterations of the fibrinolytic system. For the assessment of the residual level of liver synthesis we used pseudo-cholinesterase and serum albumin as references. We did not find a correlation between these quantities and antithrombin III or fibrinogen, but highly significant inverse correlations with tissue plaminogen activator activity and D-dimer concentration. We found considerable alterations in the concentrations of the coagulation and fibri-nolysis factors, with the exception of fibrinogen and plasminogen activator inhibitor. Signif...
The hemostatic balance in patients with liver diseases is relatively well preserved due to concomita...
Coagulation disorders in liver diseases, especially cirrhosis occurs due to a complex play between p...
SUMMARY The frequent occurrence of abnormal fibrin polymerisation in patients with liver disease has...
In the setting of liver cirrhosis (LC), profound hemostatic changes occur, which affect primary hemo...
The respective roles of intravascular coagulation (DIC) and fibrinolysis were assessed in severe chr...
The liver is the main site of synthesis and/or clearance of proteins involved in fibrinolysis. There...
Clinical obsavations on fibrinolytic phenomena have been presented in chronic diseases of the liver ...
In patients with liver cirrhosis, especially in the advanced stage, the coexistence of low clotting ...
Patients suffering from hepatic cirrhosis of moderate or advanced degree frequently have an ill-defi...
Patients with decompensated liver cirrhosis have significantly impaired synthetic function. Many pro...
This work was undertaken to examine dynamic aspects between fibrinolytic factors and clinical findin...
The clotting process is a dynamic array of multiple processes which can be described in four phases:...
Fibrin(ogen) degradation product (FDP) and D-dimer levels were evaluated in 168 liver cirrhosis (LC)...
The objective of this study was to investigate whether ascites favours the occurrence of systemic hy...
The incidence of hyperfibrinolysis in patients with cirrhosis is still debated. The reasons for this...
The hemostatic balance in patients with liver diseases is relatively well preserved due to concomita...
Coagulation disorders in liver diseases, especially cirrhosis occurs due to a complex play between p...
SUMMARY The frequent occurrence of abnormal fibrin polymerisation in patients with liver disease has...
In the setting of liver cirrhosis (LC), profound hemostatic changes occur, which affect primary hemo...
The respective roles of intravascular coagulation (DIC) and fibrinolysis were assessed in severe chr...
The liver is the main site of synthesis and/or clearance of proteins involved in fibrinolysis. There...
Clinical obsavations on fibrinolytic phenomena have been presented in chronic diseases of the liver ...
In patients with liver cirrhosis, especially in the advanced stage, the coexistence of low clotting ...
Patients suffering from hepatic cirrhosis of moderate or advanced degree frequently have an ill-defi...
Patients with decompensated liver cirrhosis have significantly impaired synthetic function. Many pro...
This work was undertaken to examine dynamic aspects between fibrinolytic factors and clinical findin...
The clotting process is a dynamic array of multiple processes which can be described in four phases:...
Fibrin(ogen) degradation product (FDP) and D-dimer levels were evaluated in 168 liver cirrhosis (LC)...
The objective of this study was to investigate whether ascites favours the occurrence of systemic hy...
The incidence of hyperfibrinolysis in patients with cirrhosis is still debated. The reasons for this...
The hemostatic balance in patients with liver diseases is relatively well preserved due to concomita...
Coagulation disorders in liver diseases, especially cirrhosis occurs due to a complex play between p...
SUMMARY The frequent occurrence of abnormal fibrin polymerisation in patients with liver disease has...